Your session is about to expire
← Back to Search
EUS-Guided Biopsy vs Aspiration for Pancreatic Cancer
Study Summary
This trial is testing if a less invasive method of testing for pancreatic tumors is just as effective as the current standard method.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am scheduled for an endosonography.I am younger than 18 or older than 90.My blood does not clot properly even after treatment.My pancreatic tumor is mostly made up of cysts.There are no masses found during an endosonography.I am between 18 and 90 years old.I have a solid mass in my pancreas seen on scans, without a biopsy done yet.My blood clotting tests are normal or can be corrected.
- Group 1: Fine Needle Aspiration and Core Biospsy
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA sanctioned Fine Needle Aspiration (FNA) and Core biopsy (FNB)?
"Our team rated the safety of Fine Needle Aspiration (FNA) and Core biopsy (FNB) to be a 3, as this treatment is already approved for use in Phase 4 trials."
Is this research program still open to taking on new participants?
"By referencing the clinicaltrials.gov data, it is apparent that this trial has been inactive since 2012; however, there are a plethora of other studies currently recruiting patients at present."
Who has the opportunity to participate in this clinical investigation?
"This clinical trial is enrolling 40 participants with cancer, ranging from 18 to 90 years of age. To qualify for this study, applicants must have a solid lesion within the pancreas on imaging scans and normal coagulation levels that can be corrected by fresh frozen plasma. Moreover, they must demonstrate English fluency and comprehension as well as having signed an informed consent form before scheduling diagnostic endosonography."
Are adults aged 18 and above admissible for this investigation?
"As per the provided guidelines, this research requires patients to be between 18 and 90 years of age. Additionally, there are 308 trials specifically for minors while 2707 clinical studies are tailored towards individuals over 65."
Share this study with friends
Copy Link
Messenger